SOURCE: Corporate Profile LLC

December 03, 2010 08:00 ET

Corporate Profile's Publishes Lenard Bogner's Update on Rexahn Pharmaceuticals

NEW YORK, NY--(Marketwire - December 3, 2010) - Corporate Profile's financial website announces Lenard Bogner's update of Rexahn Pharmaceutical, Inc. (NYSE Amex: RNN). 

To view update go to: or

About features Gene Marcial, Ray Dirks, Lenard Bogner and Goldman Small Cap Research. The website and newsletter provide readers and subscribers fresh, original, and highly informative ideas and market commentary that they won't get anywhere else. Content is focused on what is going on in the stock market and on Wall Street, including stories about large-capitalization as well as small-cap companies.

About Corporate is a broadcasting website where Fashion meets Finance.

About Bogner Business Associates

Leonard Bogner is President of Bogner Business Associates LLC. Prior to forming his consulting organization in 1994, Mr. Bogner spent more than 20 years on Wall Street as a Senior equities research analyst (mainly at Prudential Securities), where he followed major diversified chemical and micro-cap companies. He was a perennial Institutional Investor All-Star selection and named to the Wall Street Journal  "Best Analysts" list in Chemicals in 1989, 1992 and 1993. Prior to joining Wall Street, Mr. Bogner worked as a Senior Editor on McGraw-Hill's Chemical Week Magazine, where he received the prestigious Jesse H. Neal Award from the American Business Press for articles relating to "Nader vs. DuPont." He has served as a Director of a public company, and worked with a leading private equity group's Executive Network.

Safe Harbor Disclaimer
Under The Private Securities Litigation Reform Act of 1995: Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. These risks and uncertainties are described in the Company's periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectation.